Crossmark

Evaluating the safety and efficacy of nirmatrelvir-ritonavir therapy in pregnant women with COVID-19: a systematic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s00228-025-03808-8

Published Online: 2025-02-13

Published Print: 2025-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassan, Omar https://orcid.org/0009-0007-3566-4076
Elbhairy, Aya Abdulkarim https://orcid.org/0009-0001-6318-2855
Siam, Aya Magdy https://orcid.org/0009-0002-8616-6644
Abdelwahab, Tasneem https://orcid.org/0009-0002-3176-6909
Hamad, Albraa Ashraf https://orcid.org/0009-0000-5444-1424
Mahmoud, Omar Ehab https://orcid.org/0009-0003-7180-5260
Nabeh, Omnia Azmy https://orcid.org/0000-0001-7959-9316
License Information

Text and Data Mining valid from 2025-02-13

Version of Record valid from 2025-02-13
More Information

Article History

Received: 8 October 2024

Accepted: 25 January 2025

First Online: 13 February 2025

Declarations

:

: The authors declare no competing interests.

: Not applicable.

: Not applicable.